TY - JOUR
T1 - Why should survivors of childhood renal tumor and others with only one kidney be denied the chance to play contact sports?
AU - Spreafico, Filippo
AU - Terenziani, Monica
AU - Van Den Heuvel-Eibrink, Marry M.
AU - Pritchard-Jones, Kathy
AU - Levitt, Gill
AU - Graf, Norbert
AU - Bergeron, Christophe
AU - Massimino, Maura
PY - 2014/4
Y1 - 2014/4
N2 - Over the last few decades advances in the treatment of childhood and young adult cancer have greatly improved survival. As a result most children diagnosed with Wilms' tumor (the most common renal tumor in childhood) or other renal tumors become long-term survivors, living with surgically solitary kidneys. As physical activity is gaining credibility as a therapy enhancing well-being, encouraging cancer survivors do exercise during adolescence and adulthood is advisable. Discussing current evidence-based information would help to provide a framework for the harmonization of guidelines for sport participation of childhood and young adult renal tumor survivors.
AB - Over the last few decades advances in the treatment of childhood and young adult cancer have greatly improved survival. As a result most children diagnosed with Wilms' tumor (the most common renal tumor in childhood) or other renal tumors become long-term survivors, living with surgically solitary kidneys. As physical activity is gaining credibility as a therapy enhancing well-being, encouraging cancer survivors do exercise during adolescence and adulthood is advisable. Discussing current evidence-based information would help to provide a framework for the harmonization of guidelines for sport participation of childhood and young adult renal tumor survivors.
KW - athletic renal injuries
KW - renal injuries
KW - solitary kidney
KW - sport activities
KW - Wilms tumor
UR - http://www.scopus.com/inward/record.url?scp=84896990512&partnerID=8YFLogxK
U2 - 10.1586/14737140.2014.882234
DO - 10.1586/14737140.2014.882234
M3 - Review article
C2 - 24506147
AN - SCOPUS:84896990512
SN - 1473-7140
VL - 14
SP - 363
EP - 366
JO - Expert Review of Anticancer Therapy
JF - Expert Review of Anticancer Therapy
IS - 4
ER -